USPTO serial 79099606
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JOHN P. MURTAUGH
JOHN P. MURTAUGH PEARNE & GORDON LLP1801 EAST 9TH STREET, SUITE 1200CLEVELAND, OH 44114-3108UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetic products, namely, cosmetics and make-up, blush, lipsticks; hair lotions; dentifrices; skin cosmetic products, namely, creams, toilet milk, lotions, eye gel, shaving gel, shower gel, bath gel, make-up powders, body creams and hand creams; soaps; perfumery; essential oils; shampoo; cosmetic products containing microorganisms, namely, cosmetics, skin lotions, and skin creams containing probiotic microorganisms; cosmetic products containing preparations and products derived from the manufacture of micro-organisms, in particular, metabolites obtained from the processing of probiotic micro-organisms and metabolites without allergens, namely, cosmetics, skin lotions, skin creams; cosmetics products and suspensions comprising micro-organisms, in particular, probiotic micro-organisms in liquid, solid, dried or freeze-dried, namely, cosmetics, skin lotions, skin creams; cosmetic products and suspensions containing said micro-organisms and essential oils, in particular, vegetable oils or fats or waxes, namely, cosmetics, skin lotions, skin creams; cosmetic products and suspensions containing said micro-organisms coated with vegetable oils, fats and waxes, namely, cosmetics, skin lotions, skin creams | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceuticals for the treatment of inflammations of the skin, skin diseases, dermatitis, atopic dermatitis, eczema, disorders of the immune system and allergies; supplements, in particular dietary and nutritional supplements for medical use; dietetic substances, in particular, dietetic substances in the nature of dietetic beverages, dietetic foods, dietetic sugar for medical use; pharmaceuticals for the treatment of inflammations of the skin, skin diseases, dermatitis, atopic dermatitis, eczema, disorders of the immune system and allergies; supplements, in particular, dietary and nutritional supplements for medical use, all the above for internal use or for external use, in particular, in liquid, suspension and solid form, all the above being for oral administration, in particular, in capsules, tablets, pills, solutions, suspensions, granules and granulated form in dried or lyophilized, all the above being for topical administration, in particular, in creams, gel, hair lotions, ointments and oils; pharmaceuticals for the treatment of inflammations of the skin, skin diseases, dermatitis, atopic dermatitis, eczema, disorders of the immune system and allergies; dietary and nutritional supplements and dietetic substances in the nature of dietetic beverages, dietetic foods, dietetic sugar for medical use containing micro-organisms, in particular probiotic micro-organisms; pharmaceuticals for the treatment of inflammations of the skin, skin diseases, dermatitis, atopic dermatitis, eczema, disorders of the immune system and allergies; dietary and nutritional supplements and dietetic substances in the nature of dietetic beverages, dietetic foods, dietetic sugar for medical use containing preparations and products derived from the manufacture of micro-organisms, in particular, metabolites obtained from the processing of probiotic micro-organisms and metabolites without allergens; pharmaceuticals for the treatment of inflammations of the skin, skin diseases, dermatitis, atopic dermatitis, eczema, disorders of the immune system and allergies; dietary and nutritional supplements and dietetic substances in the nature of dietetic beverages, dietetic foods, dietetic sugar for medical use comprising said micro-organisms and natural oils, in particular vegetable oils, fats and waxes; pharmaceuticals for the treatment of inflammations of the skin, skin diseases, dermatitis, atopic dermatitis, eczema, disorders of the immune system and allergies; dietary and nutritional supplements and dietetic substances in the nature of dietetic beverages, dietetic foods, dietetic sugar for medical use containing said micro-organisms coated with vegetable oils, fats and waxes; vaccines for veterinary or medical use, in particular, vaccines containing micro-organism cultures, in particular, probiotic microorganisms and micro-organisms without allergens; influenza vaccines and antiviral vaccines containing micro-organism cultures, in particular, probiotic micro-organisms and micro-organisms without allergens; pharmaceuticals for the treatment and elimination of bacteria, fungi and viruses from the skin and mucous membranes | SECTION 71 - CANCELLED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 14, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 14, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 17, 2021 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 15, 2021 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 25, 2019 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 1, 2019 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 1, 2019 | INPC | INVALIDATION PROCESSED | — |
| Sep 25, 2019 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 25, 2019 | C71T | CANCELLED SECTION 71 | — |
| Jun 19, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 17, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 26, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 27, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 15, 2012 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 21, 2012 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 21, 2012 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 19, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 19, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 3, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 3, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 14, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 29, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 27, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 27, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2012 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 15, 2012 | ALIE | ASSIGNED TO LIE | — |
| Feb 7, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 7, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 7, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 7, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 27, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 10, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 10, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 10, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 9, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 8, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 2, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 27, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 22, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |